Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 4, 2006, Pages 652-658

  Bray, Freddie ^a,b,d   Richiardi, Lorenzo ^e   Ekbom, Anders ^f   Forman, David ^g   Pukkala, Eero ^h   Cuninkova, Martina ⁱ   Møller, Henrik ^b,c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e UNIVERSITY OF TURIN   (Italy)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h FINNISH CANCER REGISTRY   (Finland)

ⁱ INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONSEMINOMA; PRIORITY JOURNAL; RATING SCALE; SEMINOMA; SWITZERLAND; TESTIS CANCER;

ADOLESCENT; ADULT; AGE FACTORS; COHORT STUDIES; EPIDEMIOLOGIC STUDIES; EUROPE; GEOGRAPHY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES; SEMINOMA; TESTICULAR NEOPLASMS;

EID: 33646265784     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0565     Document Type: Article

References (50)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publications No. 155 ed. Lyon: IARC Press; 2002.
2. Zheng T, Holford TR, Ma Z, et al. Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935-1992. Int J Cancer 1996;65:723-9.
3. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. Lyon: IARC; 1993.
4. Adami HO, Bergstrom R, Mohner M, et al. Testicular cancer in nine northern European countries. Int J Cancer 1994;59:33-8.
5. Forman D, Moller H. Testicular cancer. Cancer Surv 1994;19/20:323-41.
6. Bergstrom R, Adami HO, Mohner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996;88:727-33.
7. Richiardi L, Bellocco R, Adami HO, et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 2004;13:2157-66.
8. Swerdlow AJ, Stiller CA, Wilson LM. Prenatal factors in the aetiology of testicular cancer: an epidemiological study of childhood testicular cancer deaths in Great Britain, 1953-73. J Epidemiol Community Health 1982;36:96-101.
9. Swerdlow AJ, Huttly SR, Smith PG. Prenatal and familial associations of testicular cancer. Br J Cancer 1987;55:571-7.
10. Moller H, Skakkebaek NE. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control 1997;8:904-12.
11. Akre O, Ekbom A, Hsieh CC, Trichopoulos D, Adami HO. Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst 1996;88:883-9.
12. Sabroe S, Olsen J. Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: a case-cohort study based on midwives' records in Denmark. Int J Cancer 1998;78:140-3.
13. Wanderas EH, Grotmol T, Fossa SD, Tretli S. Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 1998;9:475-86.
14. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 2000;87:438-43.
15. Dieckmann KP, Endsin G, Pichlmeier U. How valid is the prenatal estrogen excess hypothesis of testicular germ cell cancer? A case control study on hormone-related factors. Eur Urol 2001;40:677-83.
16. Richiardi L, Akre O, Bellocco R, Ekbom A. Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer 2002;87:545-50.
17. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983;71:1151-5.
18. Pike MC, Chilvers CED, Bobrow LG. Classification of testicular cancer in incidence and mortality statistics. Br J Cancer 1987;56:83-5.
19. Moss AR, Osmond D, Bacchetti P, Torti FM, Gurgin V. Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol 1986;124:39-52.
20. Prener A, Hsieh CC, Engholm G, Trichopoulos D, Jensen OM. Birth order and risk of testicular cancer. Cancer Causes Control 1992;3:265-72.
21. Coupland CA, Chilvers CE, Davey G, et al. Risk factors for testicular germ cell tumours by histological tumour type. United Kingdom Testicular Cancer Study Group. Br J Cancer 1999;80:1859-63.
22. Stone JM, Sandeman TF, Ironside P, Cruickshank DG, Matthews JP. Time trends in accuracy of classification of testicular tumours, with clinical and epidemiological implications. Br J Cancer 1992;66:396-401.
23. McGlynn KA, Devesa SS, Sigurdson AJ, et al. Trends in the incidence of testicular germ cell tumors in the United States. Cancer 2003;97:63-70.
24. Wanderas EH, Tretli S, Fossa SD. Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer 1995;31A:2044-8.
25. Moller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993;23:8-13.
26. Weir HK, Marrett LD, Moravan V. Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996 [see comments]. CMAJ 1999;160:201-5.
27. Liu S, Semenciw R, Waters C, et al. Clues to the aetiological heterogeneity of testicular seminomas and non-seminomas: time trends and age-period-cohort effects. Int J Epidemiol 2000;29:826-31.
28. European Network of Cancer Registries. EUROCIM version 4.0. Lyon: European Network of Cancer Registries; 2001.
29. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in five continents. Vol. VI. Lyon: IARC Press; 1992.
30. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents. Vol. VII. Lyon: IARC Press; 1997.
31. McCullagh P, Nelder JA. Generalized linear models. 2nd ed. London: Chapman and Hall; 1989.
32. Stata Statistical Software. Version 8.0. College Station (TX): Stata Corp. LP; 2003.
33. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 1987;6:449-67.
34. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: age-period- cohort models. Stat Med 1987;6:469-81.
35. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983;39:311-24.
36. Moller H. Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 1989;81:1668-9.
37. Holford TR. Age period cohort analysis. Encyclopedia of biostatistics. chichester: John Wiley & Sons; 1998. p. 82-99.
38. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005;5:210-22.
39. Looijenga LH, Oosterhuis JW. Pathobiology of testicular germ cell tumors: views and news. Anal Quant Cytol Histol 2002;24:263-79.
40. Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987;10:19-28.
41. Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer 2005;116:331-9.
42. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004;22:2-14.
43. Moger TA, Aalen OO, Halvorsen TO, Storm HH, Tretli S. Frailty modelling of testicular cancer incidence using Scandinavian data. Biostatistics 2004;5:1-14.
44. Levi F, Te VC, Randimbison L, la Vecchia C. Trends in testicular cancer incidence in Vaud, Switzerland. Eur J Cancer Prev 2003;12:347-9.
45. Kaldor JK, Day NE. Mathematical models in cancer epidemiology. 2nd ed. In: Schottenfeld D, Fraumeni-JF J, editors. Cancer epidemiology and prevention. New York: Oxford; 1996. p. 127-37.
46. dos Santos Silva I, Swerdlow AJ, Stiller CA, Reid A. Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. Int J Cancer 1999;83:630-4.
47. Boyle P, Kaye SB, Robertson AG. Changes in testicular cancer in Scotland. Eur J Cancer Clin Oncol 1987;23:827-30.
48. English PB, Goldberg DE, Wolff C, Smith D. Parental and birth characteristics in relation to testicular cancer risk among males born between 1960 and 1995 in California (United States). Cancer Causes Control 2003;14:815-25.
49. Pearce N, Sheppard RA, Howard JK, Fraser J, Lilley BM. Time trends and occupational differences in cancer of the testis in New Zealand. Cancer 1987;59:1677-82.
50. Pukkala E, Weiderpass E. Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971-95. Int J Cancer 2002;102:643-8.